GLOMERULAR DISEASE
Clinical trials for GLOMERULAR DISEASE explained in plain language.
Never miss a new study
Get alerted when new GLOMERULAR DISEASE trials appear
Sign up with your email to follow new studies for GLOMERULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Kidney disease drug faces Long-Term safety test
Disease control Recruiting nowThis study follows patients who previously participated in zigakibart trials to monitor long-term safety and effectiveness for IgA nephropathy, a chronic kidney disease. About 220 adults will receive the drug every two weeks for up to two years while researchers track side effect…
Matched conditions: GLOMERULAR DISEASE
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug duo aims to halt silent kidney damage
Disease control Recruiting nowThis study is testing whether combining two existing drugs, rituximab and cyclosporine, is safe and more effective for treating membranous nephropathy, an autoimmune disease that damages the kidneys' filters. The goal is to reduce harmful protein loss in urine and achieve lasting…
Matched conditions: GLOMERULAR DISEASE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Patients share their stories to shape future kidney disease treatments
Knowledge-focused Recruiting nowThis study aims to understand how swelling affects the daily lives of children and adults with Nephrotic Syndrome, a serious kidney disease. Researchers will conduct interviews with patients and parents to learn about their experiences. The information gathered will be used to cr…
Matched conditions: GLOMERULAR DISEASE
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC